Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy
使用负变构调节剂靶向PAR-2可增加肿瘤抗原呈递并增强抗PD-1免疫疗法的效果。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013507
Aouad, Samya; Kadiri, Maleck; Allard, David; Skora, Emma; Giraud, Lucie; Fuselier, Camille; Desroys du Roure, Penelope; Mousson, Antoine; Janvier, Aurelie; Baron, Luc; Franchet, Christel; Lecru, Lola; Routy, Bertrand; Malo, Julie; Brugat, Thibaut; Blayo, Anne-Laure; Schann, Stephan; Stagg, John
